BRCA1 and neoplasm: Using partly this approach in this study, we show that the combination of LCM and NGS technologies further enhances the sensitivity of identification of rare mutations from trace amounts of tumor cells and can help reveal the fine molecular details of the emergence of BRCA1/2 mutations and tumorigenesis.